Implementation of a Very Low Calorie Diet for Remission of Type 2 Diabetes in the Community

Sponsor
The University of The West Indies (Other)
Overall Status
Unknown status
CT.gov ID
NCT03536377
Collaborator
(none)
100
4
1
21.7
25
1.2

Study Details

Study Description

Brief Summary

The complications associated with uncontrolled type-2 diabetes mellitus (T2DM) are numerous; reducing the quality of life for the patient and consuming a considerable portion of healthcare finances.

The Health of the Nation (HotN) 2011 study reported that 50% of the Barbadian population

65years old had a diagnosis of T2DM and that two-thirds of the population were overweight - which is a risk factor for the development of T2DM.

Encouraged by the success of the Counterpoint study in the United Kingdom (UK), the Barbados Diabetes Reversal Study 1 (BDRS1) was established using a similar protocol; the aim of which was to evaluate the feasibility of implementing a very low calorie diet to reverse T2DM in Barbados. At the end of the 8-week intervention period, the 25 participants had achieved an average weight loss of 10.1kg (22lbs). This was accompanied by an increase in the number of participants whose fasting blood sugars were now within normal range despite being off of their diabetes medication; and a decrease in the number of participants taking blood pressure medication. Participants transitioned to a solid diet over a 4-week period, with guidance on health dietary habits and regular exercise routines. The benefits accrued during the intervention phase were preserved at the end of the transition period.

We now propose the Barbados Diabetes Remission Study 2 (BDRS2) as a sustainable community intervention - utilizing the local church as the community site. We hypothesize that this will enhance reach while reducing the cost of the study and will also facilitate the structures necessary for the social support of the participant.

Condition or Disease Intervention/Treatment Phase
  • Other: very low calorie liquid diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Implementation of a Very Low Calorie Diet for Remission of Type 2 Diabetes in the Community
Actual Study Start Date :
Feb 11, 2019
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: very low calorie liquid diet

Phase 1: Caloric restriction Phase 2: Solid diet Phase 3: Transition to independence

Other: very low calorie liquid diet
Phase 1: very low calorie liquid formulation Phase 2: Nutritionally balanced solid diet Phase 3: Educational material

Outcome Measures

Primary Outcome Measures

  1. change in weight [enrolment, 12 weeks, 6 mths and 1 year]

  2. change in fasting glucose [Enrolment, 12 weeks, 6 months, 1 year]

  3. change in Hba1C [Enrolment, 12 weeks, 6 months, 1 year]

Secondary Outcome Measures

  1. change in waist circumference [Enrolment, 12 weeks, 6 months, 1 year]

  2. change in blood pressure [Enrolment, 12 weeks, 6 months, 1 year]

    both the systolic and diastolic pressures will be measured

  3. change in blood pressure medication [weekly for the first 12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults aged 20 - 70 years old, all ethnicities

  • Diagnosis of T2DM for <6 years as defined by the American Diabetes Association

  • Diagnosis of pre-diabetes as defined by the American Diabetes Association

  • Body Mass index (BMI) of 27 kg/m2 and over

Exclusion Criteria:
  • Insulin use

  • Substance abuse

  • Current cancer diagnosis

  • myocardial infarction within last 6 month

  • learning difficulties

  • current treatment with anti-obesity drugs

  • diagnosed eating disorder or purging

  • HbA1c > 10%

  • pregnant/considering pregnancy

  • evidence of liver disease (including liver enzymes > 3 times above normal values)

  • evidence of renal disease (creatinine of > 150 mmol/l)

  • persons who have required hospitalisation for depression, or are on antipsychotic drugs

Contacts and Locations

Locations

Site City State Country Postal Code
1 Abundant Life Assembly Bridgetown Bank Hall, Saint Michael Barbados
2 Ellerton Wesleyan Church Bridgetown Ellerton, Saint George Barbados
3 River Road New Testament Church of God Bridgetown River Road, Saint Michael Barbados
4 Mount of Praise Wesleyan Church Bridgetown Tudor Bridge, Saint Michael Barbados

Sponsors and Collaborators

  • The University of The West Indies

Investigators

  • Study Chair: T Alafia Samuels, MBBS, PhD, George Alleyne Chronic Disease Research Centre, The University of the West Indies

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
The University of The West Indies
ClinicalTrials.gov Identifier:
NCT03536377
Other Study ID Numbers:
  • BDRS2
First Posted:
May 24, 2018
Last Update Posted:
Mar 28, 2019
Last Verified:
May 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The University of The West Indies
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2019